PHEAST
Live / Registered — Registered (as of 28 Jul 2026)
What this means for you
Registered since 28 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 97295204
- Registration number
- 8368425
- Mark type
- Word mark
- Filed
- 04 Mar 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 28 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 28 Jul 2032 (grace period to 28 Jan 2033)
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical and biological research services; research and development of pharmaceuticals for the treatment of cancer; medical testing services and information in the field of cancer research
Owner
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 28 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2026 — USE AMENDMENT FILED
- 12 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 09 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2026 — SOU EXTENSION 5 GRANTED
- 21 Nov 2025 — SOU EXTENSION 5 FILED
- 30 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED